Impact of pre-morbid depression on health-related quality of life in non-demented Parkinson's disease patients

Parkinsonism and Related Disorders

Volumn 16, Issue 1, 2010, Pages 21-27

  Klepac, Nataša ^a   Hajnšek, Sanja ^a   Trkulja, Vladimir ^b  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Depression; Health related quality of life; Motor symptoms; Non motor symptoms; Parkinson's disease

Indexed keywords

ALPRAZOLAM; AMANTADINE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; ENTACAPONE; LEVODOPA; OXAZEPAM; PRAMIPEXOLE; RASAGILINE; ROPINIROLE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; EMOTIONAL STABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP;

AGED; ANALYSIS OF VARIANCE; DEPRESSION; FEMALE; HEALTH STATUS; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MORBIDITY; PARKINSON DISEASE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 74149088465     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2009.07.003     Document Type: Article

References (23)

1. Ebrahim S. Clinical and public health perspectives and applications of health-related quality of life measurement. Soc Sci Med 41 (1995) 1383-1394
2. Chaudhuri K.R., Healy D.G., and Schapira A.H.V. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5 (2006) 235-245
3. Visser M., van Rooden S.M., Verbaan D., Marinus J., Stiggelbout A.M., and van Hilten J.J. A comprehensive model of health-related quality of life in Parkinson's disease. J Neurol 255 (2008) 1580-1587
4. Dowding C.H., Shenton C.L., and Salek S.S. A review of the health-related quality of life and economic impact of Parkinson's disease. Drugs Aging 23 (2006) 693-721
5. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci 248 (2006) 151-157
6. Veazey C., Aki S.O.E., Cook K.F., Lai C.E., and Kunik M.E. Prevalence and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 17 (2005) 310-323
7. Slaughter J.R., Slaughter K.A., Nichols D., Holmes S.E., and Martens M.P. Prevalence, clinical manifestations, etiology and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 13 (2001) 187-196
8. Leentjens A.F.G. Depression in Parkinson's disease: conceptual issues and clinical challenges. J Geriatr Psychiatry Neurol 17 (2004) 120-126
9. Ishihara L., and Brayne C. A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand 113 (2006) 211-220
10. Ishihara L., and Brayne C. What is the evidence for a premorbid parkinsonian personality: a systematic review. Mov Disord 21 (2006) 1066-1072
11. Klepac N, Trkulja V. Longer education favors milder depressive difficulties and better health-related quality of life in non-demented Parkinson's disease patients. J Neuropsychiatry Clin Neurosci, in press.
12. Gibb W.R.G., and Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51 (1988) 745-752
13. Crum R.M., Anthony J.C., Bassett S.S., and Folstein M.F. Population-based norms for the mini-mental state examination by age and educational level. JAMA 18 (1993) 2386-2391
14. Benton A., De Hamsher S.K., and Sivan A. Multilingual aphasia examination. 3rd ed. (1983), AJA Associates, Iowa City
15. Smith A. Symbol digit modalities test: manual (1991), Western Psychological Services, Los Angeles
16. Reitan R.M. Trail making test. Manual for administration and scoring (1992), Reitan Neuropsychology Laboratory, South Tucson
17. Preacher K.J., and Hayes A.F. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 40 (2008) 879-891
18. Ishihara-Paul L., Wainwright N.W., Khaw K.T., Luben R.N., Welch A.A., Day N.E., et al. Prospective association between emotional health and clinical evidence of Parkinson's disease. Eur J Neurol 15 (2008) 1148-1154
19. Cui X., Lyness J.M., Tu X., King D.A., and Caine D.E. Does depression precede or follow executive dysfunction? Outcomes in older primary care patients. Am J Psychiatry 164 (2007) 1221-1228
20. Baron R.M., and Kenny D.A. The moderator-mediator variable distinction in social psychological research; conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51 (1986) 1173-1182
21. Damasio A.R. Emotion in the perspective of an integrated nervous system. Brain Res Brain Res Rev 26 (1998) 83-86
22. MacKinnon D.P., Krull J.L., and Lockwood C.M. Equivalence of the mediation, confounding and suppression effect. Prev Sci 1 (2000) 173-181
23. Cahn D.A., and Sullivan E.V. Differential contributions of cognitive and motor component processes to physical and instrumental activities of daily living in Parkinson's disease. Arch Clin Neuropsychol 7 (1998) 575-583